Skip to main content

Table 1 Genomic and transcriptomic datasets

From: Pan-cancer analysis identifies BIRC5 as a prognostic biomarker

Cancer type and pan-organ system

Cohort

Number of samples

Genetic alterationsa

RNA-seqa

Co-expressiona

KM plotter

Cancer tissue

Normal tissue

Central nervous system

 Glioblastoma multiforme

GBM

592

166

5

145

 

 Brain lower grade carcinoma

LGG

514

530

0

511

 

Endocrine

 Adrenocortical carcinoma

ACC

91

79

0

78

 

 Thyroid carcinoma

THCA

500

496

58

480

 

Gastrointestinal

 Cholangiocarcinoma

CHOL

36

36

9

36

 

 Colon adenocarcinoma

COADb

594

191

0

524

 

 Rectum adenocarcinoma

READ

72

0

 

 Esophageal Adenocarcinoma

ESCAc

182

185

11

181

 

 Esophageal squamous carcinoma

 Liver hepatocellular carcinoma

LIHC

372

147

50

348

 

 Pancreatic adenocarcinoma

PAAD

184

56

0

168

 

 Stomach adenocarcinoma

STADf

440

415

35

407

875

Gynecologic

 Breast invasive carcinoma

BRCA

1084

1026

108

994

1879

 Cervical squamous cell carcinoma

CESCd

297

159

0

275

 

 Ovarian serous cystadenocarcinoma

OV

584

265

0

201

1656

 Uterine corpus endometrial carcinoma

UCEC

529

369

0

507

 

Head and neck

 Head and neck squamous cell carcinoma

HNSC

523

425

42

488

 

Hematologic and lymphatic malignancies

 Diffuse Large B-cell Lymphoma

DLBC

41

48

0

37

 

 Acute myeloid leukemia

LAML

200

173

0

165

 

 Thymoma

THYM

123

120

0

119

 

Melanocytic

 Skin cutaneous melanoma

SKCM

444

472

0

363

 

 Uveal melanoma

UVM

80

80

0

80

 

Neural crest-derived

 Pheochromocytoma and paraganglioma

PCPG

178

184

3

161

 

Soft tissue

 Sarcoma

SARC

255

105

0

251

 

 Uterine carcinosarcoma

UCS

57

57

0

56

 

Thoracic

 Lung adenocarcinoma

LUADe

566

490

58

503

1925

 Lung squamous cell carcinoma

LUSCe

487

482

50

466

 Mesothelioma

MESO

87

87

0

82

 

Urologic

 Bladder urothelial carcinoma

BLCA

411

223

19

402

 

 Kidney chromophobe

KICH

65

66

25

65

 

 Kidney renal clear cell carcinoma

KIRC

511

507

72

352

 

 Kidney renal papillary cell carcinoma

KIRP

283

161

30

274

 

 Prostate adenocarcinoma

PRAD

494

498

52

488

 

 Testicular germ cell tumors

TGCT

145

156

0

144

 

Total

 

8812

8526

627

9351

6335

  1. aTCGA data, see Method
  2. bIn bioPortal COAD+READ was combined for our analysis
  3. cIn RNA-seq data esophageal adenocarcinoma and squamous carcinoma were combined. In analysis of RNA-seq data for gene co-expression there was only data for esophageal adenocarcinoma
  4. dWhen analyzing gene co-expression using the RNA-seq data, cervical squamous cell carcinoma and endocervical adenocarcinoma were both included
  5. eIn KM-plotter both LUAD and LUSC were included in analysis
  6. fStomach cancer was in KM plotter denominated as gastric cancer